DEFECTIVE SIGNALING THROUGH THE T-CELL AND B-CELL ANTIGEN RECEPTORS IN LYMPHOLD CELLS LACKING THE VAV PROTOONCOGENE

被引:375
作者
ZHANG, R
ALT, FW
DAVIDSON, L
ORKIN, SH
SWAT, W
机构
[1] CHILDRENS HOSP,DIV HEMATOL ONCOL,BOSTON,MA 02115
[2] CHILDRENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115
[4] HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115
[5] HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115
[6] CTR BLOOD RES,BOSTON,MA 02115
关键词
D O I
10.1038/374470a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
THE product of the vav proto-oncogene(1), p95(vav) or Vav, is tyrosine phosphorylated upon stimulation of T and B cells by antigen(2-4) and other(5-8) receptors, and contains motifs associated,vith signal transduction(1,9-11). To determine its role in vivo, we used vav-gene-targeted embryonic stem(12) cells and RAG-2(-/-) blastocyst complementation(13). The vav(-/-)-RAG-2(-/-) chimaeras displayed thymic atrophy with reduced numbers of peripheral T cells. Whereas the total number of B cells was normal, the subset of peritoneal B-1 (CD5(+))(14) cells was missing. The vav(-/-) T and B cells were hyporeactive when stimulated through antigen receptors, but vav(-/-) T cells proliferated on exposure to phorbol ester and calcium ionophore(15), whereas B cells responded normally to bacterial mitogen, lipopolysaccharide or the CD40 ligand(16-18). Thus, we have established here a functional role for vav in the control of T- and B-cell development and activation.
引用
收藏
页码:470 / 473
页数:4
相关论文
共 26 条
[1]  
Katzav S., Martin-Zanca D., Barbacid M., EMBO J, 8, pp. 2283-2290, (1989)
[2]  
Bustelo X.R., Ledbetter J.A., Barbacid M., Nature, 356, pp. 68-71, (1992)
[3]  
Busteio X.R., Barbacid M., Science, 256, pp. 1196-1199, (1992)
[4]  
Margolis B., Et al., Nature, 356, pp. 71-74, (1992)
[5]  
Alai M., Et al., J. Biol. Chem, 267, pp. 18021-18025, (1992)
[6]  
Piatanias L.C., Sweet M.E., J. Biol. Chem, 269, pp. 3143-3146, (1994)
[7]  
Kiener P.A., Et al., J. Biol. Chem, 268, pp. 24442-24448, (1993)
[8]  
Evans G.A., Howard O.M.Z., Erwin R., Farrar W.L., Biochem. J., 294, pp. 339-342, (1993)
[9]  
Adams J.M., Houston H., Alien J., Lints T., Harvey R., Oncogene, 7, pp. 611-618, (1992)
[10]  
Bustelo X.R., Rubin S.D., Suen K.L., Carrasco D., Barbacid M., Cell Growth Differ, 4, pp. 297-308, (1993)